Preconditioning and postconditioning reduce hepatic ischemia-reperfusion injury in rats. 2009

Wan-Xing Zhang, and Wen Yin, and Lei Zhang, and Lan-Hui Wang, and Lei Bao, and Hong-Fang Tuo, and Li-Fang Zhou, and Chun-Cheng Wang
Department of Hepatobiliary Surgery, Hebei Provincial General Hospital, Shijiazhuang 050051, China. zhangwx12@hotmail.com

BACKGROUND Ischemia-reperfusion injury occurs when ischemic tissues or organs suffer from further functional and structural damage when their blood supply recovers. This study aimed to contrast the protective effects of ischemic preconditioning and ischemic postconditioning in hepatic ischemia-reperfusion injury in rats. METHODS Thirty-two healthy male Wistar rats were randomly divided into four groups: sham-operated (SO), ischemia-reperfusion (IR), ischemic preconditioning (I-pre), and ischemic postconditioning (I-post). Blood samples and hepatic tissue were taken from all groups after the experiments. RESULTS There were significant differences between the IR, I-pre and I-post groups in alanine aminotransferase and aspartate aminotransferase levels, NF-kappaB p65 expression, apoptosis index and superoxide dismutase activity in hepatic tissue. There were no significant differences between the I-pre and I-post groups. CONCLUSIONS Ischemic postconditioning and ischemic preconditioning reduce hepatic ischemia-reperfusion injury, but in clinical practice the former is a more appropriate choice.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001219 Aspartate Aminotransferases Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1. Aspartate Aminotransferase,Aspartate Transaminase,Glutamic-Oxaloacetic Transaminase,SGOT,Aspartate Apoaminotransferase,Glutamate-Aspartate Transaminase,L-Aspartate-2-Oxoglutarate Aminotransferase,Serum Glutamic-Oxaloacetic Transaminase,Aminotransferase, Aspartate,Aminotransferase, L-Aspartate-2-Oxoglutarate,Aminotransferases, Aspartate,Apoaminotransferase, Aspartate,Glutamate Aspartate Transaminase,Glutamic Oxaloacetic Transaminase,Glutamic-Oxaloacetic Transaminase, Serum,L Aspartate 2 Oxoglutarate Aminotransferase,Serum Glutamic Oxaloacetic Transaminase,Transaminase, Aspartate,Transaminase, Glutamate-Aspartate,Transaminase, Glutamic-Oxaloacetic,Transaminase, Serum Glutamic-Oxaloacetic
D013482 Superoxide Dismutase An oxidoreductase that catalyzes the reaction between SUPEROXIDES and hydrogen to yield molecular oxygen and hydrogen peroxide. The enzyme protects the cell against dangerous levels of superoxide. Hemocuprein,Ag-Zn Superoxide Dismutase,Cobalt Superoxide Dismutase,Cu-Superoxide Dismutase,Erythrocuprein,Fe-Superoxide Dismutase,Fe-Zn Superoxide Dismutase,Iron Superoxide Dismutase,Manganese Superoxide Dismutase,Mn-SOD,Mn-Superoxide Dismutase,Ag Zn Superoxide Dismutase,Cu Superoxide Dismutase,Dismutase, Ag-Zn Superoxide,Dismutase, Cobalt Superoxide,Dismutase, Cu-Superoxide,Dismutase, Fe-Superoxide,Dismutase, Fe-Zn Superoxide,Dismutase, Iron Superoxide,Dismutase, Manganese Superoxide,Dismutase, Mn-Superoxide,Dismutase, Superoxide,Fe Superoxide Dismutase,Fe Zn Superoxide Dismutase,Mn SOD,Mn Superoxide Dismutase,Superoxide Dismutase, Ag-Zn,Superoxide Dismutase, Cobalt,Superoxide Dismutase, Fe-Zn,Superoxide Dismutase, Iron,Superoxide Dismutase, Manganese
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

Wan-Xing Zhang, and Wen Yin, and Lei Zhang, and Lan-Hui Wang, and Lei Bao, and Hong-Fang Tuo, and Li-Fang Zhou, and Chun-Cheng Wang
August 2007, Chinese journal of traumatology = Zhonghua chuang shang za zhi,
Wan-Xing Zhang, and Wen Yin, and Lei Zhang, and Lan-Hui Wang, and Lei Bao, and Hong-Fang Tuo, and Li-Fang Zhou, and Chun-Cheng Wang
January 2013, Mediators of inflammation,
Wan-Xing Zhang, and Wen Yin, and Lei Zhang, and Lan-Hui Wang, and Lei Bao, and Hong-Fang Tuo, and Li-Fang Zhou, and Chun-Cheng Wang
June 2019, Journal of anesthesia,
Wan-Xing Zhang, and Wen Yin, and Lei Zhang, and Lan-Hui Wang, and Lei Bao, and Hong-Fang Tuo, and Li-Fang Zhou, and Chun-Cheng Wang
October 2007, Journal of applied physiology (Bethesda, Md. : 1985),
Wan-Xing Zhang, and Wen Yin, and Lei Zhang, and Lan-Hui Wang, and Lei Bao, and Hong-Fang Tuo, and Li-Fang Zhou, and Chun-Cheng Wang
February 2004, Surgery,
Wan-Xing Zhang, and Wen Yin, and Lei Zhang, and Lan-Hui Wang, and Lei Bao, and Hong-Fang Tuo, and Li-Fang Zhou, and Chun-Cheng Wang
February 2014, Molecular medicine reports,
Wan-Xing Zhang, and Wen Yin, and Lei Zhang, and Lan-Hui Wang, and Lei Bao, and Hong-Fang Tuo, and Li-Fang Zhou, and Chun-Cheng Wang
September 2010, International journal of cardiology,
Wan-Xing Zhang, and Wen Yin, and Lei Zhang, and Lan-Hui Wang, and Lei Bao, and Hong-Fang Tuo, and Li-Fang Zhou, and Chun-Cheng Wang
April 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
Wan-Xing Zhang, and Wen Yin, and Lei Zhang, and Lan-Hui Wang, and Lei Bao, and Hong-Fang Tuo, and Li-Fang Zhou, and Chun-Cheng Wang
January 2014, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences,
Wan-Xing Zhang, and Wen Yin, and Lei Zhang, and Lan-Hui Wang, and Lei Bao, and Hong-Fang Tuo, and Li-Fang Zhou, and Chun-Cheng Wang
April 2010, Acta cirurgica brasileira,
Copied contents to your clipboard!